<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Extraction extraction-result-198 - Theorizer</title>
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.15.1/css/all.min.css">
    <link rel="stylesheet" href="../style.css">
</head>
<body>
    <div class="header">
        <a href="../index.html"><i class="fas fa-flask"></i> Theorizer</a>
    </div>

    <div class="content">
        <h1>Extracted Data Details for extraction-result-198</h1>

        <div class="section">
            <h2>Extracted Data (Header)</h2>
            <div class="info-section">
                <p><strong>Extraction ID:</strong> extraction-result-198</p>
                <p><strong>Extraction Schema Used (ID):</strong> <a href="../schemas/extraction-schema-2.html">extraction-schema-2</a></p>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of EGFR mutation frequencies in different ethnic or geographic populations, particularly comparing East Asian and non-Asian populations, along with any proposed mechanisms, risk factors, or explanations for these differences.</div>
                <p><strong>Paper ID:</strong> paper-164502a687f04effb4ac5dadbdd9d806fde4264c</p>
                <p><strong>Paper Title:</strong> <a href="https://www.semanticscholar.org/paper/164502a687f04effb4ac5dadbdd9d806fde4264c" target="_blank">Lung adenocarcinoma from East Asian never-smokers is a disease largely defined by targetable oncogenic mutant kinases.</a></p>
                <p><strong>Paper Venue:</strong> Journal of Clinical Oncology</p>
                <p><strong>Paper TL;DR:</strong> This study represents the first comprehensive and concurrent analysis of major recurrent oncogenic mutations found in a large cohort of lung adenocarcinomas from East Asian never-smokers and indicates that prospective mutation testing in these patients should successfully assign a targeted therapy in the majority of cases.</p>
                <p><strong>Cost:</strong> 0.009</p>
            </div>
        </div>

        <div class="section">
            <h2>Extracted Data (Details)</h2>
            <div class="extraction-instance-container" id="e198.0">
                <h3 class="extraction-instance">Extracted Data Instance 0 (e198.0)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of EGFR mutation frequencies in different ethnic or geographic populations, particularly comparing East Asian and non-Asian populations, along with any proposed mechanisms, risk factors, or explanations for these differences.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>EGFR (East Asian never-smokers)</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Epidermal Growth Factor Receptor kinase domain mutations in lung adenocarcinomas from East Asian never-smokers</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>This study reports a very high prevalence of activating EGFR kinase-domain mutations in resected lung adenocarcinomas from Chinese never-smokers, with detailed breakdowns by exon and some clinical correlates (sex, co-mutations).</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Lung Adenocarcinoma From East Asian Never-Smokers Is a Disease Largely Defined by Targetable Oncogenic Mutant Kinases</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>use</td>
                        </tr>
                        <tr>
                            <td><strong>study_population</strong></td>
                            <td>Chinese (East Asian) never-smokers with resected lung adenocarcinoma; N = 52 (100% Chinese; 41 female, 11 male).</td>
                        </tr>
                        <tr>
                            <td><strong>egfr_mutation_frequency</strong></td>
                            <td>78.8% (41 of 52 tumors; 95% CI 0.6580 to 0.8792).</td>
                        </tr>
                        <tr>
                            <td><strong>comparison_populations</strong></td>
                            <td>No direct quantitative non-Asian frequencies provided in this paper; the paper states EGFR mutations are enriched in East Asian ethnicity compared with non-Asian populations and cites prior studies (qualitative comparison).</td>
                        </tr>
                        <tr>
                            <td><strong>specific_mutation_types</strong></td>
                            <td>Exon 19 deletions: 21 cases; Exon 21 L858R: 18 cases; Exon 20 insertion: 1 case; double mutation G719S (exon 18) + L861Q (exon 21): 1 case; T790M: not detected in this cohort. (Total mutated = 41.)</td>
                        </tr>
                        <tr>
                            <td><strong>smoking_status_association</strong></td>
                            <td>Paper emphasizes EGFR mutations are strongly associated with never-smoking status; within this never-smoker cohort EGFR mutations were more frequent in females (82.9%: 34 of 41 female cases) than males (63.6%: 7 of 11 male cases). The paper also cites prior work showing EGFR mutation likelihood decreases as pack-years increase (i.e., more smoking associated with fewer EGFR mutations).</td>
                        </tr>
                        <tr>
                            <td><strong>environmental_factors</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>genetic_factors</strong></td>
                            <td>Mentions germline T790M as a rare variant (not observed here). Notes ethnic differences in other genes (eg, LKB1 mutations reported more frequently in Caucasians than Asians in cited literature), implying genetic background may differ by ethnicity; also reports co-occurrence of PIK3CA mutations with EGFR mutations in four tumors (possible modifier of drug response). No specific germline SNPs or DNA-repair variants are proposed in this paper as causal explanations.</td>
                        </tr>
                        <tr>
                            <td><strong>biological_mechanisms</strong></td>
                            <td>The paper does not propose a specific molecular mechanism explaining higher EGFR mutation prevalence in East Asians; it discusses that EGFR, HER2, and ALK driver mutations define molecular subsets and that co-mutations (eg, PIK3CA) or exon 20 insertions can modify TKI sensitivity. It implies population/etiologic differences (smoking exposure and sex) correlate with mutation patterns but offers no mechanistic causal model for ethnic differences.</td>
                        </tr>
                        <tr>
                            <td><strong>lung_cancer_subtype</strong></td>
                            <td>Adenocarcinoma (resected lung adenocarcinomas).</td>
                        </tr>
                        <tr>
                            <td><strong>demographic_factors</strong></td>
                            <td>Sex: strong female predominance in cohort (41 female, 11 male) and higher EGFR mutation rate in females (82.9% vs 63.6% in males). Age: mean ≈59 years (no strong age association reported). Smoking status: all are never-smokers by study design.</td>
                        </tr>
                        <tr>
                            <td><strong>proposed_explanation</strong></td>
                            <td>The paper attributes high EGFR mutation prevalence primarily to the combination of East Asian ethnicity and never-smoking status (clinical associations observed in prior studies), and notes that some mutations that affect TKI response (exon 20 insertions, concurrent PIK3CA) partially explain variable clinical responses; it also suggests differences in frequencies of other genes (eg, LKB1 more common in Caucasians) point to ethnic genomic differences, but it does not present a definitive causal explanation for the ethnic/geographic differences in EGFR mutation frequency.</td>
                        </tr>
                        <tr>
                            <td><strong>counterevidence_or_confounds</strong></td>
                            <td>Confounds noted include: (1) smoking exposure effect — EGFR mutation frequency decreases with increasing pack-years (cited ref), so differences across populations could reflect different smoking histories; (2) small, highly selected sample (single Chinese center, never-smokers, N=52) limits generalizability; (3) concurrent mutations (eg, PIK3CA) or resistant EGFR variants (exon 20 insertions) alter predicted TKI sensitivity and may affect observed response rates; (4) other driver events (non-EML4 ALK fusions, ROS fusions, PDGFRα amplifications) might be missed if not assayed and could complicate interpretation of ethnic patterns; (5) the paper provides qualitative comparisons to non-Asian populations but no direct quantitative frequencies for those populations in this report.</td>
                        </tr>
                        <tr>
                            <td><strong>notes</strong></td>
                            <td>This paper is an empirical report of EGFR mutation prevalence in Chinese never-smokers and cites prior studies (including IPASS and reports in white never-smokers) when discussing enrichment of EGFR mutations in East Asians and never-smokers.</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Lung adenocarcinoma from East Asian never-smokers is a disease largely defined by targetable oncogenic mutant kinases.', 'publication_date_yy_mm': '2010-10'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
        </div>

        <div class="section">
            <h2>Potentially Relevant New Papers (mentioned by this paper)</h2>
            <ol>
                <li>Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma <em>(Rating: 2)</em></li>
                <li>Screening for epidermal growth factor receptor mutations in lung cancer <em>(Rating: 2)</em></li>
                <li>Use of cigarette-smoking history to estimate the likelihood of mutations in epidermal growth factor receptor gene exons 19 and 21 in lung adenocarcinomas <em>(Rating: 2)</em></li>
                <li>Reversed mutation rates of KRAS and EGFR genes in adenocarcinoma of the lung in Taiwan and their implications <em>(Rating: 2)</em></li>
                <li>Mutations in the LKB1 tumour suppressor are frequently detected in tumours from Caucasian but not Asian lung cancer patients <em>(Rating: 2)</em></li>
                <li>Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib <em>(Rating: 1)</em></li>
            </ol>
        </div>

        </div>

    </div>
</body>
</html>